{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:01:48Z","timestamp":1780725708109,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003062","name":"Erciyes \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016209","name":"Erciyes University Scientific Research Projects Coordination Unit","doi-asserted-by":"publisher","award":["TTU-2022-11600"],"award-info":[{"award-number":["TTU-2022-11600"]}],"id":[{"id":"10.13039\/501100016209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpsychires.2025.09.038","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T06:47:22Z","timestamp":1758869242000},"page":"363-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Drug blood levels, influencing factors and their relationship with metabolic parameters in patients with schizophrenia using clozapine"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1412-5731","authenticated-orcid":false,"given":"G\u00f6kcen","family":"Kumandas Sigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2757-9641","authenticated-orcid":false,"given":"Saliha","family":"Ozsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Karakukcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2277-0730","authenticated-orcid":false,"given":"Hatice","family":"Saracoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1448-6502","authenticated-orcid":false,"given":"Salim Cagatay","family":"Kagizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2025.09.038_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112506","article-title":"A systematic review of sex-based differences in effectiveness and adverse effects of clozapine","volume":"280","author":"Alberich","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4088\/JCP.09m05402yel","article-title":"Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study","volume":"72","author":"Bai","year":"2011","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.genm.2009.12.004","article-title":"Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review","volume":"6","author":"Bigos","year":"2009","journal-title":"Gend. Med."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14740338.2020.1698545","article-title":"The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy","volume":"19","author":"Costa-Dookhan","year":"2020","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FTD.0b013e3181dad1fb","article-title":"Plasma clozapine, norclozapine, and the clozapine: norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993\u20132007","volume":"32","author":"Couchman","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2042098618756261","article-title":"Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine","volume":"9","author":"De Berardis","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.30773\/pi.2022.0293","article-title":"Reflections on the lack of consideration of ethnic ancestry to stratify clozapine dosing","volume":"20","author":"de Leon","year":"2023","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1176\/appi.psy.46.3.262","article-title":"The dosing of atypical antipsychotics","volume":"46","author":"de Leon","year":"2005","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/JCP.0b013e31802e513a","article-title":"Weight gain during a double-blind multidosage clozapine study","volume":"27","author":"de Leon","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000507638","article-title":"A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology","volume":"89","author":"de Leon","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12384","article-title":"Using therapeutic drug monitoring to personalize clozapine dosing in Asians","volume":"12","author":"de Leon","year":"2020","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/a-1625-6388","article-title":"An international adult Guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels","volume":"55","author":"de Leon","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib13","article-title":"Five genetic polymorphisms of cytochrome P450 enzymes in the Czech non-Roma and Czech roma population samples","volume":"35","author":"Dlouh\u00e1","year":"2020","journal-title":"Drug Metab Pers Ther"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10110840","article-title":"Clozapine: an updated overview of pharmacogenetic biomarkers, risks, and safety-particularities in the context of COVID-19","volume":"10","author":"Dragoi","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/JCP.0b013e3181f03e30","article-title":"The participation of cytochrome P450 3A4 in clozapine biotransformation is detected in people with schizophrenia by high-throughput in vivo phenotyping","volume":"30","author":"Ghassabian","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib16","series-title":"ECDEU Assessment Manual for Psychopharmacology\/William Guy. U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib17","series-title":"The Relationship of Comorbidities and Side Effects with the Sociodemographic and Clinical Variables in Schizophrenia Patients Treated with Clozapine","author":"G\u00fcrcan","year":"2016"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00228-006-0209-9","article-title":"The effect of variable cigarette consumption on the interaction with clozapine and olanzapine","volume":"62","author":"Haslemo","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12888-022-03910-6","article-title":"Factors predicting serum clozapine levels in Middle Eastern patients: an observational study","volume":"22","author":"Hassab Errasoul","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib20","doi-asserted-by":"crossref","first-page":"11115","DOI":"10.1073\/pnas.1220919110","article-title":"Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes","volume":"110","author":"Iqbal","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113056","article-title":"The relationship between serum clozapine concentrations and hematological parameters by a validated mass spectrometric method","volume":"180","author":"Kamil Gharab","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib24","first-page":"23","article-title":"Reliability and validity of the Turkish version of the positive and negative syndrome scale (PANSS)","volume":"14","author":"Kostako\u011flu A","year":"1999","journal-title":"T\u00fcrk Psikol. Derg."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.9740\/mhc.2023.12.276","article-title":"Ethnopsychopharmacology: clinical and scientific writing pearls","volume":"13","author":"Leung","year":"2023","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2147\/NDT.S163839","article-title":"Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations","volume":"14","author":"Mayerova","year":"2018","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78474-0","article-title":"Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia","volume":"10","author":"Menus","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib29","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/17425255.2021.1974400","article-title":"Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies","volume":"17","author":"Molden","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib30","series-title":"National Institute for Health and Clinical Excellence: Guidance, Psychosis and Schizophrenia in Adults: Treatment and Management: Updated Edition 2014","year":"2014"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1192\/bjp.2023.27","article-title":"Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis","volume":"222","author":"Northwood","year":"2023","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S2215-0366(23)00002-0","article-title":"Pharmacokinetics and pharmacogenomics of clozapine in an ancestrally diverse sample: a longitudinal analysis and genome-wide association study using UK clinical monitoring data","volume":"10","author":"Pardinas","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib33","first-page":"235","article-title":"Gender differences in psychotropic drug metabolism","volume":"33","author":"Pollock","year":"1997","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/02698811241241394","article-title":"Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder","volume":"38","author":"Rafizadeh","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/bcp.15691","article-title":"A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status","volume":"90","author":"Reeves","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-012-2922-7","article-title":"Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?","volume":"225","author":"Remington","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eurpsy.2013.11.002","article-title":"EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness","volume":"29","author":"R\u00fcther","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib38","first-page":"1505","article-title":"Metabolic adverse effects of psychotropic drug therapy: a systematic review","volume":"13","author":"Sep\u00falveda-Lizcano","year":"2023","journal-title":"Eur. J. Investig. Health Psychol. Educ."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2020.05.057","article-title":"Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study","volume":"222","author":"Suhas","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00213-020-05746-y","article-title":"A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions","volume":"238","author":"Tan","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004216","article-title":"Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine","volume":"4","author":"Tsuda","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.12740\/PP\/65307","article-title":"Therapeutic drug monitoring of atypical antipsychotics","volume":"51","author":"Urban","year":"2017","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5505\/kpd.2022.56688","article-title":"Relationship of clozapine serum levels with gender, smoking and symptom severity (Tur)","volume":"25","author":"Y\u0131ld\u0131zhan","year":"2022","journal-title":"J Clin Psy"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/JCP.0b013e3181855cbc","article-title":"Weight gain and first-generation antipsychotics: experience from a developing country","volume":"28","author":"Yoon","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.609240","article-title":"A focused review of the metabolic side-effects of clozapine","volume":"12","author":"Yuen","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/YCO.0000000000000417","article-title":"New findings in pharmacogenetics of schizophrenia","volume":"31","author":"Zai","year":"2018","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib47","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/03602530903286476","article-title":"Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2","volume":"42","author":"Zhou","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpsychires.2025.09.038_bib48","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.metabol.2004.04.017","article-title":"Lifestyle behaviors associated with lower risk of having the metabolic syndrome","volume":"53","author":"Zhu","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.jpsychires.2025.09.038_bib49","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.euroneuro.2016.07.010","article-title":"A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome","volume":"26","author":"Zimbron","year":"2016","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625005618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625005618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:05:34Z","timestamp":1780722334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625005618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"alternative-id":["S0022395625005618"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.09.038","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug blood levels, influencing factors and their relationship with metabolic parameters in patients with schizophrenia using clozapine","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}